Novel therapy shows promise for lung cancer patients with rare EGFR mutation

Researchers report on a multinational, early phase clinical trial evaluating a new targeted therapy for patients with metastatic or unresectable non-small cell lung cancer who have a specific genetic mutation: EGFR Ex20Ins.

from Top Health News -- ScienceDaily https://ift.tt/3s48sBb